Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing immunotherapies for cancer and infectious disease, said its chief executive and chief.
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be presenti
Multiple published studies show that needle-free improves vaccine effectiveness PharmaJet, a company who has developed and commercialized a needle-free platform to more effectively administer drugs